These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 18507062)

  • 1. Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.
    Zhao H; Chen Y; Liao YP; Chen HM; Yang QH; Xiao Y; Luo J; Chen ZZ; Yi L; Hu GY
    Clin Exp Med; 2023 Feb; 23(1):55-64. PubMed ID: 35239073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.
    Kim M; Hwang HS; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
    J Pathol Transl Med; 2021 Sep; 55(5):330-337. PubMed ID: 34465079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.
    Wang C; Wang Y; Cao J; Sun X; He X; Sun P; Gao T; Huang J; Li Z
    Ann Hematol; 2021 Sep; 100(9):2293-2302. PubMed ID: 33991204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma.
    Yamashita T; Vollbrecht C; Hirsch B; Kleo K; Anagnostopoulos I; Hummel M
    J Clin Exp Hematop; 2020; 60(3):87-96. PubMed ID: 32981916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
    Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
    J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.
    Zeggai S; Harir N; Tou A; Sellam F; Mrabent MN; Salah R
    J Gastrointest Oncol; 2016 Jun; 7(3):462-8. PubMed ID: 27284480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
    Huang JJ; Xia Y; Wang Y; Liu PP; Bi XW; Sun P; Lin TY; Jiang WQ; Li ZM
    Oncotarget; 2016 Jul; 7(27):41242-41250. PubMed ID: 27183909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
    Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
    Mahjabeen I; Ali K; Zhou X; Kayani MA
    Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis.
    He X; Chen Z; Fu T; Jin X; Yu T; Liang Y; Zhao X; Huang L
    BMC Cancer; 2014 Mar; 14():153. PubMed ID: 24597851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a bioassay to monitor circulating plasma Ki-67.
    Hardiman G
    Leuk Res; 2010 Jul; 34(7):848-9. PubMed ID: 20172610
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
    Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
    Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
    Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant non-Hodgkin's lymphoma of the joint. Report of two cases, review of the literature and problems of classification].
    Krüger R; Oden J; de Leon F; Dürr W
    Unfallchirurg; 1993 Oct; 96(10):556-62. PubMed ID: 8235678
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.